ClinicalTrials.govpublic full text
Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
leukemia, myelocytic, acute, primary aml, risk-adapted treatment, hematopoietic transplantation, cd34+ cell selection, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873936
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.